Cellectis (CLLS) Gross Margin Growth (3y) (2018 - 2023)
Cellectis (CLLS) Gross Margin Growth (3y) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 722.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -191.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -162.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -40.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 25,815.00 |
| Sep 30, 2023 | -11,022.00 |
| Jun 30, 2023 | 17,003.00 |
| Mar 31, 2023 | -23,111.00 |
| Dec 31, 2022 | 2,805.00 |
| Sep 30, 2022 | -15,957.00 |
| Jun 30, 2022 | 4,557.00 |
| Mar 31, 2022 | -4,151.00 |
| Dec 31, 2021 | -2,621.00 |
| Sep 30, 2021 | -1,503.00 |
| Jun 30, 2021 | -9,847.00 |
| Mar 31, 2021 | -9,957.00 |
| Dec 31, 2020 | -12,382.00 |
| Sep 30, 2020 | -11,726.00 |
| Jun 30, 2020 | -23,026.00 |
| Mar 31, 2020 | -5,288.00 |
| Dec 31, 2019 | -12,464.00 |
| Sep 30, 2019 | -4,704.00 |
| Jun 30, 2019 | -6,914.00 |
| Mar 31, 2019 | -5,036.00 |